Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows

Investing.com Gold reports: Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows. Full body text was unavailable at ingest time, so this brief is based on headline context.